Physician profile
David Shin
NPI 1710241831
$5,602.93
in general payments reported to CMS, 2019-2025
14 companies · $1,414 in 2025
The $1,414 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2020: $67.21 · 2021: $436 · 2022: $805 · 2023: $1,919 · 2024: $621 · 2025: $1,414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,374 · Gift: $1,544 · Education: $35.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,373.54 |
| Gift | $1,544.00 |
| Education | $35.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visionary Optics LLC | $1,988.00 | 2021-2025 | |
| Alcon Vision LLC | $1,053.92 | 2019-2025 | Argos, Precision 1, Dailies Total1 |
| Johnson & Johnson Vision Care, INC. | $565.39 | 2021-2025 | Acuvue |
| Glaukos Corporation | $516.07 | 2024-2025 | Idosetr, Istent, Ce-Marked Kxla System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $375.35 | 2019-2021 | |
| Coopervision INC. | $353.67 | 2021-2025 | Misight Contact Lens, Myday Contact Lens |
| Bausch & Lomb Americas INC. | $274.22 | 2023-2024 | Miebo, Infuse |
| Tarsus Pharmaceuticals, INC. | $165.77 | 2024-2025 | Xdemvy |
| Topcon Healthcare, INC. | $90.43 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $79.61 | 2020-2025 | Lipiflow System Activator (Disposable) |
| Carl Zeiss Meditec, INC. | $60.36 | 2019 | |
| Biotissue Holdings INC. | $42.01 | 2025 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Oyster Point Pharma, INC. | $18.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Shin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.